The Supreme Court has maintained mail access to the abortion pill mifepristone, setting aside for now a lower court order ...

By Daniel Wiessner May 14 (Reuters) - The U.S. Supreme Court has for now refused to block a U.S. Food and Drug Administration rule allowing the abortion pill mifepristone to be prescribed via a ...

The court rejects an antiabortion challenge to mifepristone, an FDA-approved medication for ending early pregnancies.

The Supreme Court has preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court ...

Abortion pills can remain available through the mail for the immediate future after the Supreme Court on Thursday paused a lower court ruling that would have blocked access while a lawsuit proceeds.

Justice Samuel Alito froze an appeals court ruling that limited access to the drug used in two-thirds of abortions.

Nearly two-thirds of abortions in the U.S. are now induced by medication, and about one-quarter involve telemedicine.

Conservative Supreme Court justices wrote a scathing dissent to the 7-2 decision to allow women to continue accessing the abortion pill Mifepristone via mail and telehealth. "What is at stake is the ...

The court’s order allows women seeking abortions to continue obtaining the drug, mifepristone, at pharmacies or through the mail, without an in-person visit to a doctor. Access is likely to remain ...

Updated on May 14 at 7:57 p.m. The Supreme Court on Thursday afternoon issued an order that continued to block a ruling by a ...